Viewing Study NCT00934518


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-02-03 @ 9:41 AM
Study NCT ID: NCT00934518
Status: WITHDRAWN
Last Update Posted: 2019-02-12
First Post: 2009-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
Sponsor: Milton S. Hershey Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Cancer of the Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Squamous cell carcinoma, Head and Neck cancer View